Skip to main content

Table 1 Published reports of M fortuitum PD-peritonitis

From: Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature

Location of the report Patient demographics Time from admission to positive culture Sensitivity Directed Treatment Tenckhoff removed Comment
Houston, USA [1] 15 y/o male 4 days S – Amikacin, trimethoprim/sulfamethoxazole, cefoxitin IV Amikacin and IV cefoxitin. (c) Yes Abscess drainage required
R- doxycycline
Portland, USA [2] 57 y/o male 7 days Not reported PO Erythromycin, IV cephapirin, IV tobramycin.(6 days) Yes Catheter leak. No abdominal pain. Patient died at 6 days.
Copenhagen, Denmark [3] 35 y/o male 11 days S – Amikacin, tobramycin, erythromycin, trimethoprim-sulfamethoxazole IV Amikacin, IV methicillin (c) Yes In renal transplant perioperative period.
Cleveland, USA [4] 32 y/o male 6 days S – Amikacin, tetracycline Amikacin, tetracycline (1 month); ciprofloxacin (c, d) Yes Reduced aural acuity after amikacin.
R – gentamicin, tobramycin, erythromycin, trimethoprim/sulfamethoxazole
Hong Kong, China [5] 65 y/o male - Not reported PO Levofloxacin, PO clarithromycin (12 months) No  
Seoul, Korea [6] 54 y/o female 7 days R – isoniazid, rifampicin, ethambutol, streptomycin IV Ceftizotime, IV amikacin (c) Yes  
Louisiana, USAb[7] 71 y/o male 7 days Not reported IP Amikacin and cefoxitin (3 weeks); PO doxycycline and rifampicin (3 months) Yes  
83 y/o female 4 days Not reported Ciprofloxacin and clofazimine (c, d) ?
Madrid, Spain [8] 42 y/o male 11 days Not reported IV Amikacin and PO doxycycline (20 days) Yes  
40 y/o male 8 days Not reported IV Amikacin and PO doxycycline (1 month) Yes
Washington, USA [9] 33 y/o male 7 days S – amikacin, kanamycin, clarithromycin, cefmetazole, imipenem, ciprofloxacin, ofloxacin, azithromycin PO Clarithromycin and PO trimethoprim/sulfamethoxazole (6 months) Yes  
71 y/o female 4 days R – tobramycin, erythromycin, doxycycline, minocycline, cefoxitin IV Amikacin, PO clarithromycin, PO trimethoprim/sulfamethoxazole (3 months) Yes
S – clarithromycin, cefmetazole, imipenem, sulfisoxazole, ciprofloxacin, ofloxacin
I – amikacin, cefoxitin
Saudi Arabia [10] 45 y/o female 7 days   PO Isoniazid, rifampicin, ethambutol. (6 months) Yes  
Nashville, USA [11] 16 y/o male 12 days   PO Ciprofloxacin, PO trimethoprim/sulfamethoxazole (c) Yes Perihepatic collection
Kfar-Saba, Israel [12] 65 y/o male 4 days   Minocycline (1 monthd) Yes Also bacteraemia
Tokyo, Japan [13] 50 y/o male 3 weeks Not reported Amikacin, sulbactam (c,d) Yes  
Singapore, Singapore b[14] 78 y/o female 8 days S – tobramycin, linezolid, clarithromycin, amikacin IP amikacin, PO ciprofloxacin (3 months) No Patient died at 2 months from malignancy
  1. aThis publication also reported on a suspected case of PD-peritonitis and two confirmed cases of Tenckhoff catheter exit site infections due to M. fortuitum.
  2. bThis publication also listed a second (male) patient with M. fortuitum PD-peritonitis in a table, but described the patient to be a female with M. abscessus PD-peritonitis in the text. Due to inconsistency in the report, this case was excluded.
  3. cDuration of therapy not known.
  4. dRoute of administration not known.
  5. IP intraperitoneal, PO per oral, IV intravenous.